Plasma arginase activity may affect the responses to sildenafil in patients with erectile dysfunction (2014)
- Authors:
- USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; COLOGNA, ADAUTO JOSE - FMRP ; LACCHINI, RICCARDO - EERP
- Unidades: FMRP; EERP
- Subjects: DISFUNÇÃO ERÉTIL; POLIMORFISMO; FÁRMACOS (SISTEMA CARDIOVASCULAR)
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Nitrite Oxide-Nitrite/Nitrate Conference
-
ABNT
LACCHINI, Riccardo et al. Plasma arginase activity may affect the responses to sildenafil in patients with erectile dysfunction. 2014, Anais.. Cleveland: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2014. . Acesso em: 31 dez. 2025. -
APA
Lacchini, R., Pinheiro, L. C., Muniz, J., Nobre, Y., Cologna, A. J., Martins, A., & Tanus-Santos, J. E. (2014). Plasma arginase activity may affect the responses to sildenafil in patients with erectile dysfunction. In Abstracts. Cleveland: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Lacchini R, Pinheiro LC, Muniz J, Nobre Y, Cologna AJ, Martins A, Tanus-Santos JE. Plasma arginase activity may affect the responses to sildenafil in patients with erectile dysfunction. Abstracts. 2014 ;[citado 2025 dez. 31 ] -
Vancouver
Lacchini R, Pinheiro LC, Muniz J, Nobre Y, Cologna AJ, Martins A, Tanus-Santos JE. Plasma arginase activity may affect the responses to sildenafil in patients with erectile dysfunction. Abstracts. 2014 ;[citado 2025 dez. 31 ] - Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction
- VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction
- Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension
- Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
- Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
- Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
